• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身 MRI 联合和不联合对比增强 Quick 3D 和双 RF 脂肪抑制技术、常规全身 MRI、PET/CT 与常规检查在评估 NSCLC 患者复发中的效用比较。

Comparison of the utility of whole-body MRI with and without contrast-enhanced Quick 3D and double RF fat suppression techniques, conventional whole-body MRI, PET/CT and conventional examination for assessment of recurrence in NSCLC patients.

机构信息

Advanced Biomedical Imaging Research Center, Kobe University Graduate School of Medicine, Japan; Division of Functional and Diagnostic Imaging Research, Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Japan.

出版信息

Eur J Radiol. 2013 Nov;82(11):2018-27. doi: 10.1016/j.ejrad.2013.07.016. Epub 2013 Sep 5.

DOI:10.1016/j.ejrad.2013.07.016
PMID:24012452
Abstract

PURPOSE

The purpose of this study was to compare diagnostic capabilities for assessment of recurrence in non-small cell lung cancer (NSCLC) patients by contrast-enhanced whole-body MRI (CE-WB-MRI) with and without CE-Quick 3D and double RF fat suppression technique (DFS), FDG-PET/CT and conventional radiological examinations.

MATERIALS AND METHODS

A total of 134 pathologically proven and completely resected NSCLC patients (78 males, 56 females; mean age: 72 years) underwent FDG-PET/CT, CE-WB-MRI with and without Quick 3D and DFS at 3T as well as conventional radiological examinations. The probability of recurrence was assessed with a 5-point scoring system on a per-patient basis, and final diagnosis was made by consensus between two readers. The capability for overall recurrence assessment by all the methods was compared by means of ROC analysis and their sensitivity, specificity and accuracy by means of McNemar's test.

RESULTS

Although areas under the curve did not show any significant differences, specificity (100%) and accuracy (95.5%) of CE-WB-MRI with CE-Quick 3D and DFS were significantly higher than those of FDG-PET/CT (specificity: 93.6%, p=0.02; accuracy: 89.6%, p=0.01) and conventional radiological examinations (specificity: 92.7%, p=0.01; accuracy: 91.0%, p=0.03). In addition, specificity of CE-WB-MRI without CE-Quick 3D and DFS (100%) was significantly higher than that of FDG-PET/CT (p=0.02) and conventional radiological examinations (p=0.01).

CONCLUSION

Specificity and accuracy of CE-WB-MRI with CE-Quick 3D and DFS for assessment of recurrence in NSCLC patients are at least as high as, or higher than those of others.

摘要

目的

本研究旨在比较对比增强全身磁共振成像(CE-WB-MRI)联合 CE-Quick 3D 和双射频脂肪抑制技术(DFS)、FDG-PET/CT 和常规影像学检查对非小细胞肺癌(NSCLC)患者复发评估的诊断能力。

材料与方法

共纳入 134 例经病理证实且完全切除的 NSCLC 患者(78 例男性,56 例女性;平均年龄:72 岁),在 3T 磁共振扫描仪上分别进行 FDG-PET/CT、CE-WB-MRI 联合或不联合 Quick 3D 和 DFS 以及常规影像学检查。每位患者采用 5 分制评分系统评估复发概率,由两位读者共同协商得出最终诊断。通过 ROC 分析比较所有方法对整体复发评估的能力,并通过 McNemar 检验比较其敏感性、特异性和准确性。

结果

尽管曲线下面积无显著差异,但 CE-WB-MRI 联合 CE-Quick 3D 和 DFS 的特异性(100%)和准确性(95.5%)明显高于 FDG-PET/CT(特异性:93.6%,p=0.02;准确性:89.6%,p=0.01)和常规影像学检查(特异性:92.7%,p=0.01;准确性:91.0%,p=0.03)。此外,CE-WB-MRI 不联合 CE-Quick 3D 和 DFS 的特异性(100%)明显高于 FDG-PET/CT(p=0.02)和常规影像学检查(p=0.01)。

结论

CE-WB-MRI 联合 CE-Quick 3D 和 DFS 对 NSCLC 患者复发评估的特异性和准确性至少与其他方法相当,或更高。

相似文献

1
Comparison of the utility of whole-body MRI with and without contrast-enhanced Quick 3D and double RF fat suppression techniques, conventional whole-body MRI, PET/CT and conventional examination for assessment of recurrence in NSCLC patients.全身 MRI 联合和不联合对比增强 Quick 3D 和双 RF 脂肪抑制技术、常规全身 MRI、PET/CT 与常规检查在评估 NSCLC 患者复发中的效用比较。
Eur J Radiol. 2013 Nov;82(11):2018-27. doi: 10.1016/j.ejrad.2013.07.016. Epub 2013 Sep 5.
2
Non-small cell carcinoma: comparison of postoperative intra- and extrathoracic recurrence assessment capability of qualitatively and/or quantitatively assessed FDG-PET/CT and standard radiological examinations.非小细胞癌:定性和/或定量评估的 FDG-PET/CT 与标准影像学检查对术后胸内和胸外复发评估能力的比较。
Eur J Radiol. 2011 Sep;79(3):473-9. doi: 10.1016/j.ejrad.2010.04.027. Epub 2010 May 23.
3
Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.非小细胞肺癌患者骨转移的检测:全身扩散加权成像(DWI)、有无DWI的全身磁共振成像、全身氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)及骨闪烁显像的比较
J Magn Reson Imaging. 2009 Aug;30(2):298-308. doi: 10.1002/jmri.21858.
4
Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.非小细胞肺癌:用于M分期评估的全身磁共振检查——全身扩散加权成像与一体化氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG PET/CT)相比的效用
Radiology. 2008 Aug;248(2):643-54. doi: 10.1148/radiol.2482072039. Epub 2008 Jun 6.
5
Diagnostic performance of different imaging modalities in the assessment of distant metastasis and local recurrence of tumor in patients with non-small cell lung cancer.不同影像学方法在评估非小细胞肺癌患者肿瘤远处转移和局部复发中的诊断性能。
J Magn Reson Imaging. 2017 Dec;46(6):1707-1717. doi: 10.1002/jmri.25726. Epub 2017 Apr 17.
6
Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.全身磁共振成像结合弥散加权成像:在侵袭性淋巴瘤初始分期中是对比增强CT的一种有价值的替代方法。
Clin Radiol. 2016 Mar;71(3):271-9. doi: 10.1016/j.crad.2015.11.018. Epub 2015 Dec 31.
7
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.与氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描(FDG-PET-CT)相比,使用1.5T和3T全身磁共振成像(MRI)对乳腺癌患者肿瘤复发进行综合成像。
Eur J Radiol. 2008 Jan;65(1):47-58. doi: 10.1016/j.ejrad.2007.10.021. Epub 2007 Dec 20.
8
Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.对比增强磁共振成像与正电子发射断层扫描/计算机断层扫描联合评估卵巢肿块
Invest Radiol. 2014 Aug;49(8):524-31. doi: 10.1097/RLI.0000000000000050.
9
Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer patients.使用3T MR系统的快速自旋回波(FASE)序列进行扩散加权磁共振成像:通过使用回波平面成像(EPI)序列的扩散加权磁共振成像、短TI反转恢复快速自旋回波(STIR FASE)成像和氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG PET/CT)对非小细胞肺癌患者进行N分期评估能力的初步比较。
Eur J Radiol. 2015 Nov;84(11):2321-31. doi: 10.1016/j.ejrad.2015.07.019. Epub 2015 Jul 26.
10
Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients.全身 MRI、同机融合全身 18F-FDG PET/MR 与全身 18F-FDG PET/CT 成像的三方比较:非小细胞肺癌患者的 TNM 和分期评估能力。
Radiology. 2015 Jun;275(3):849-61. doi: 10.1148/radiol.14140936. Epub 2015 Jan 14.

引用本文的文献

1
Deep Learning Reconstruction to Improve the Quality of MR Imaging: Evaluating the Best Sequence for T-category Assessment in Non-small Cell Lung Cancer Patients.深度学习重建以提高磁共振成像质量:评估非小细胞肺癌患者T分期评估的最佳序列
Magn Reson Med Sci. 2024 Oct 1;23(4):487-501. doi: 10.2463/mrms.mp.2023-0068. Epub 2023 Sep 1.
2
State of the Art MR Imaging for Lung Cancer TNM Stage Evaluation.用于肺癌TNM分期评估的磁共振成像技术现状
Cancers (Basel). 2023 Feb 2;15(3):950. doi: 10.3390/cancers15030950.
3
State-of-the-art MR Imaging for Thoracic Diseases.
胸部疾病的最新磁共振成像技术。
Magn Reson Med Sci. 2022 Mar 1;21(1):212-234. doi: 10.2463/mrms.rev.2020-0184. Epub 2021 Apr 29.
4
Extramammary findings on breast MRI: prevalence and imaging characteristics favoring malignancy detection: a retrospective analysis.乳腺MRI的乳腺外表现:有利于恶性肿瘤检测的患病率及影像特征:一项回顾性分析
World J Surg Oncol. 2016 Apr 21;14:119. doi: 10.1186/s12957-016-0865-x.
5
Non-small-cell lung cancer resectability: diagnostic value of PET/MR.非小细胞肺癌的可切除性:PET/MR的诊断价值
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):49-55. doi: 10.1007/s00259-014-2873-9. Epub 2014 Aug 15.